Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 471074, 10 pages
http://dx.doi.org/10.1093/ecam/neq033
Original Article

Anti-Inflammatory Potential of Ethanolic Leaf Extract of Eupatorium adenophorum Spreng. Through Alteration in Production of TNF-α, ROS and Expression of Certain Genes

1Immunology and Cell Biology Laboratory, Department of Zoology, School of life Sciences, University of North Bengal, Siliguri 734013, India
2Former Joint Director, SeriBiotech, Ministry of Textiles, Government of India, Kolkata, India

Received 28 September 2009; Accepted 22 March 2010

Copyright © 2011 Ashim K. Chakravarty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Simmons, “What makes a good anti-inflammatory drug target?” Drug Discovery Today, vol. 11, no. 5-6, pp. 210–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Saukkonen, S. Sande, C. Cioffe et al., “The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis,” Journal of Experimental Medicine, vol. 171, no. 2, pp. 439–448, 1990. View at Google Scholar · View at Scopus
  3. N. L. Parenteau and J. Hardin-Young, “The biological mechanisms behind injury and inflammation: how they can affect treatment strategy, product performance, and healing,” Wounds, vol. 19, no. 4, pp. 87–96, 2007. View at Google Scholar · View at Scopus
  4. L. M. Fabbri, M. Saetta, G. Picotti, and C. E. Mapp, “Late asthmatic reactions, airway inflammation and chronic asthma in toluene-diisocyanate-sensitized subjects,” Respiration, vol. 58, no. 1, pp. 18–21, 1991. View at Google Scholar · View at Scopus
  5. R. J. Stevens, K. M. J. Douglas, A. N. Saratzis, and G. D. Kitas, “Inflammation and atherosclerosis in rheumatoid arthritis,” Expert Reviews in Molecular Medicine, vol. 7, no. 7, pp. 1–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Klareskog, L. Padyukov, J. Rönnelid, and L. Alfredsson, “Genes, environment and immunity in the development of rheumatoid arthritis,” Current Opinion in Immunology, vol. 18, no. 6, pp. 650–655, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Simka, “Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis,” Current Neurovascular Research, vol. 6, no. 2, pp. 132–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. D. Zipser, “Mediators of inflammation in inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 33, no. 3, pp. 4S–5S, 1988. View at Google Scholar · View at Scopus
  9. J. Drews and S. Ryser, “Classic drug targets,” Nature Biotechnology, vol. 15, pp. 1318–1319, 1997. View at Google Scholar
  10. D.-X. Kong, X.-J. Li, and H.-Y. Zhang, “Where is the hope for drug discovery? Let history tell the future,” Drug Discovery Today, vol. 14, no. 3-4, pp. 115–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. A. AuLD and P. M. Martins, “The autecology of Eupatorium adenophorum Spreng. In Austraha,” Weed Research, vol. 15, pp. 27–31, 1975. View at Google Scholar
  12. L. Muschietti, M. Derita, V. Sülsen et al., “In vitro antifungal assay of traditional Argentine medicinal plants,” Journal of Ethnopharmacology, vol. 102, no. 2, pp. 233–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Ahmed, M. Arshad, M. Ahmad, M. Saeed, and M. Ishaque, “Ethnopharmacological survey of some medicinally important plkants of Galliyat areas of NWFP, Pakistan,” Asian Journal of Plant Sciences, vol. 3, pp. 410–415, 2004. View at Google Scholar
  14. P. Castillo-España, A. Cisneros-Estrada, M. L. Garduño-Ramírez, O. Hernández-Abreu, R. Ramírez, and S. Estrada-Soto, “Preliminary ethnopharmacological survey of plants used in Mexico for the treatment of hypertension,” Pharmacognosy Reviews, vol. 3, pp. 41–65, 2009. View at Google Scholar
  15. A. Pieroni, M. E. Giusti, C. de Pasquale et al., “Circum-Mediterranean cultural heritage and medicinal plant uses in traditional animal healthcare: a field survey in eight selected areas within the RUBIA project,” Journal of Ethnobiology and Ethnomedicine, vol. 2, pp. 16–27, 2006. View at Google Scholar
  16. M. Heinrich, M. Robles, J. E. West, B. R. Ortiz De Montellano, and E. Rodriguez, “Ethnopharmacology of Mexican asteraceae (compositae),” Annual Review of Pharmacology and Toxicology, vol. 38, pp. 539–565, 1998. View at Google Scholar · View at Scopus
  17. N. R. Monks, A. Ferraz, S. A. Bradgnon, K. R. Machado, M. F. Richter, and A. B. DaRocha, “In vitro cytotoxicity of extracts from Brazilian Asteraceae,” Pharmaceutical Biology, vol. 40, pp. 494–500, 2002. View at Google Scholar
  18. E. K. Akkol, U. Koca, I. Pesin, and D. Yilmazer, “Evaluation of the wound healing potential of Achillea biebersteinii Afan. (Asteraceae) by in vivo excision and incision models,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  19. S. J. Uddin, I. D. Grice, and E. Tiralongo, “Cytotoxic effects of Bangladeshi plant extracts,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  20. S. K. Mandal, R. Boominathan, B. Parimaladevi, S. Dewanjee, and S. C. Mandal, “Analgesic activity of methanol extract of Eupatorium adenophorum Spreng. leaves,” Indian Journal of Experimental Biology, vol. 43, no. 7, pp. 662–663, 2005. View at Google Scholar · View at Scopus
  21. G. K. Matsushima and S. A. Stohlman, “Maturation of the delayed-type hypersensitivity response in SJL mice: absence of effector cell induction,” European Journal of Immunology, vol. 18, no. 9, pp. 1411–1416, 1988. View at Google Scholar · View at Scopus
  22. U. Bandyopadhyay, D. Das, and R. K. Banerjee, “Reactive oxygen species: oxidative damage and pathogenesis,” Current Science, vol. 77, no. 5, pp. 658–666, 1999. View at Google Scholar · View at Scopus
  23. P. C. Dedon and S. R. Tannenbaum, “Reactive nitrogen species in the chemical biology of inflammation,” Archives of Biochemistry and Biophysics, vol. 423, no. 1, pp. 12–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Halliwell, J. R. Hoult, and D. R. Blake, “Oxidants, inflammation, and anti-inflammatory drugs,” FASEB Journal, vol. 2, no. 13, pp. 2867–2873, 1988. View at Google Scholar · View at Scopus
  25. P. J. Barnes, “Reactive oxygen species and airway inflammation,” Free Radical Biology and Medicine, vol. 9, no. 3, pp. 235–243, 1990. View at Publisher · View at Google Scholar · View at Scopus
  26. E. L. Nguemfol, T. Dimol, A. B. Dongmo et al., “Anti-oxidative and anti-inflammatory activities of some isolated constituents from the stem bark of Allanblackia monticola Staner L.C (Guttiferae),” Inflammopharmacology, vol. 17, pp. 37–41, 2009. View at Google Scholar
  27. P. Abreu, S. Matthew, T. González, D. Costa, M. A. Segundo, and E. Fernandes, “Anti-inflammatory and antioxidant activity of a medicinal tincture from Pedilanthus tithymaloides,” Life Sciences, vol. 78, no. 14, pp. 1578–1585, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Joseph, B. Sabulal, V. George, T. P. Smina, and K. K. Janardhanan, “Antioxidative and antiinflammatory activities of the chloroform extract of Ganoderma lucidum found in South India,” Scientia Pharmaceutica, vol. 77, no. 1, pp. 111–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. Dinarello, “Proinflammatory cytokines,” Chest, vol. 118, pp. 503–508, 2000. View at Google Scholar
  30. R. Strieter, S. Kunkel, and R. Bone, “Role of tumor necrosis factor-alpha in disease states and inflammation,” Critical Care Medicine, vol. 21, pp. S447–S463, 1993. View at Google Scholar
  31. N. W. Lukacs, R. M. Strieter, S. W. Chensue, M. Widmer, and S. L. Kunkel, “TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation,” Journal of Immunology, vol. 154, no. 10, pp. 5411–5417, 1995. View at Google Scholar · View at Scopus
  32. K. J. Tracey and A. Cerami, “Tumor necrosis factor: a pleiotropic cytokine and therapeutic target,” Annual Review of Medicine, vol. 45, pp. 491–503, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Schweizer, U. Feige, A. Fontana, K. Muller, and C. A. Dinarello, “Interleukin-1 enhances pain reflexes: mediation through increased prostaglandin E2 levels,” Agents Actions, vol. 25, pp. 246–251, 1998. View at Google Scholar
  34. C. Gabay, “Interleukin-6 and chronic inflammation,” Arthritis Research & Therapy, vol. 8, supplement 2, pp. S3–S8, 2006. View at Google Scholar
  35. S. Omoigui, “The interleukin-6 inflammation pathway from cholesterol to aging—role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases,” Immunity and Ageing, vol. 4, pp. 1–22, 2007. View at Google Scholar
  36. M. Jutel, M. Akdis, F. Budak et al., “IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy,” European Journal of Immunology, vol. 33, no. 5, pp. 1205–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Alkalay, A. Yaron, A. Hatzubai et al., “Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, pp. 10599–10603, 1995. View at Google Scholar
  38. V. Pande and M. J. Ramos, “NF-κB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors,” Current Medicinal Chemistry, vol. 12, no. 3, pp. 357–374, 2005. View at Google Scholar · View at Scopus
  39. P. P. Tak and G. S. Firestein, “NF-kappaB: a key role in inflammatory diseases,” Journal of Clinical Investigation, vol. 107, pp. 7–11, 2001. View at Google Scholar
  40. Y. Yamamoto and R. B. Gaynor, “Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer,” Journal of Clinical Investigation, vol. 107, pp. 135–142, 2001. View at Google Scholar
  41. M. E. Turini and R. N. DuBois, “Cyclooxygenase-2: a therapeutic target,” Annual Review of Medicine, vol. 53, pp. 35–57, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. C. J. Smith, Y. Zhang, C. M. Koboldt et al., “Pharmacological analysis of cycloxygenase 1 in inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, pp. 13313–13318, 1998. View at Google Scholar
  43. W. L. Smith, R. M. Garavito, and D. L. DeWitt, “Prostaglandin endoperoxide H synthase (cyclooxygenases)-1 and -2,” The Journal of Biological Chemistry, vol. 271, pp. 33157–33160, 1996. View at Google Scholar
  44. J. A. Mitchell, S. Larkin, and T. J. Williams, “Cyclooxygenase 2: regulation and relevance in inflammation,” Biochemical Pharmacology, vol. 50, pp. 1535–1542, 1995. View at Google Scholar
  45. J. R. Vane, Y. S. Bakhle, and R. M. Botting, “Cyclooxygenases 1 and 2,” Annual Review of Pharmacology and Toxicology, vol. 38, pp. 97–120, 1998. View at Google Scholar · View at Scopus
  46. F. Chen, S. Sun, D. C. Kuhn et al., “Involvement of NF-κB in silica-induced cyclooxygenase II gene expression in rat alveolar macrophages,” American Journal of Physiology, vol. 272, no. 4, pp. L779–L786, 1997. View at Google Scholar · View at Scopus
  47. Y. Devaux, C. Seguin, S. Grosjean et al., “Lipopolysaccharide-induced increase of prostaglandin E(2) is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase,” Journal of Immunology, vol. 167, pp. 3962–3971, 2001. View at Google Scholar
  48. A. K. Chakravarty, S. N. Chatterjee, H. Yasmin, and T. Mazumder, “Comparison of efficacy of turmeric and commercial curcumin in immunological functions and gene regulation,” International Journal of Pharmacology, vol. 5, pp. 333–345, 2009. View at Google Scholar
  49. A. K. Chakravarty and H. Yasmin, “Activation of cell mediated immune response and apoptosis towards malignant cells with turmeric treatment in murine model,” Indian Journal of Biochemistry and Biophysics, vol. 45, no. 1, pp. 23–29, 2008. View at Google Scholar · View at Scopus
  50. A. K. Chakravarty and H. Yasmin, “Alcoholic turmeric extract simultaneously activating murine lymphocytes and inducing apoptosis of Ehlrich ascitic carcinoma cells,” International Immunopharmacology, vol. 5, no. 10, pp. 1574–1581, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. A. K. Chakravarty, H. Yasmin, and S. K. Das, “Two way efficacy of alcoholic turmeric extract: stimulatory for murine lymphocytes and inhibitory for ascetic fibrosarcoma,” Pharmaceutical Biology, vol. 42, pp. 217–224, 2004. View at Google Scholar
  52. M. Iijima and S. I. Katz, “Specific immunologic tolerance to dinitrofluorobenzene following topical application of dinitrothiocyanobenzene: modulation by suppressor T cells,” Journal of Investigative Dermatology, vol. 81, no. 4, pp. 325–330, 1983. View at Google Scholar · View at Scopus
  53. A. K. Chakravarty and U. K. Maitra, “Polyclonally stimulated murine T cells in control fibrosarcoma in situ,” Journal of the Indian Institute of Science, vol. 70, pp. 503–516, 1990. View at Google Scholar
  54. R. Busch, D. Cesar, D. Higuera-Alhino, T. Gee, M. K. Hellerstein, and J. M. McCune, “Isolation of peripheral blood CD4+ T cells using RosetteSepTM and MACSTM for studies of DNA turnover by deuterium labeling,” Journal of Immunological Methods, vol. 286, pp. 97–109, 2004. View at Google Scholar
  55. M. P. Matheu and M. D. Cahalan, “Isolation of CD4+ T cells from mouse lymph nodes using Miltenyi MACS purification,” Journal of Visualized Experiments, no. 9, p. 409, 2007. View at Google Scholar · View at Scopus
  56. L. A. Stanciu and R. Djukanović, “Isolation of T-cell subsets by magnetic cell sorting (MACS),” Methods in Molecular Biology, vol. 134, pp. 133–141, 2000. View at Google Scholar · View at Scopus
  57. V. Sureshkumar, B. Paul, M. Uthirappan et al., “Pro-inflammatory and anti-inflammatory cytokine balance in gasoline exhaust induced pulmonary injury in mice,” Inhalation Toxicology, vol. 17, pp. 161–168, 2005. View at Google Scholar
  58. I. V. M. L. R. Sirish Kumar, B. N. Paul, R. Asthama, A. K. Saxena, S. Mehrotra, and G. Rajan, “Swertia Chirayita mediated modulation of interleukin-1β, interleukin-6, interleukin-10, interferon-γ and tumor necrosis factor-α in arthritic mice,” Immunopharmacology and Immunotoxicology, vol. 25, pp. 573–583, 2003. View at Google Scholar
  59. P. D. Drew and J. A. Chavis, “Female sex steroids: effects upon microglial cell activation,” Journal of Neuroimmunology, vol. 111, no. 1-2, pp. 77–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Halliwell, J. M. C. Gutteridge, and O. I. Aruoma, “The deoxyribose method: a simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicals,” Analytical Biochemistry, vol. 165, no. 1, pp. 215–219, 1987. View at Google Scholar · View at Scopus
  61. D. A. Rappolee, D. Mark, M. J. Banda, and Z. Werb, “Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping,” Science, vol. 241, pp. 708–712, 1988. View at Google Scholar
  62. D. A. Rappolee, C. A. Brenner, R. Schultz, D. Mark, and Z. Werb, “Developmental expression of PDGF, TGF-α, and TGF-β genes in preimplantation mouse embryos,” Science, vol. 241, no. 4874, pp. 1823–1825, 1988. View at Google Scholar · View at Scopus
  63. S. Ehlers, M. E. A. Mielke, and H. Hahn, “CD4+ T cell associated cytokine gene expression during experimental infection with Listeria monocytogenes: the mRNA phenotype of granuloma formation,” International Immunology, vol. 6, no. 11, pp. 1727–1737, 1994. View at Google Scholar · View at Scopus
  64. L. W. Poulter, G. J. Seymour, O. Duke, G. Janossy, and G. Panayi, “Immunohistological analysis of delayed-type hypersensitivity in man,” Cell Immunology, vol. 74, pp. 358–369, 1982. View at Google Scholar
  65. T. Banno, A. Gazel, and M. Blumenberg, “Effects of tumor necrosis factor-α (TNFα) in epidermal keratinocytes revealed using global transcriptional profiling,” Journal of Biological Chemistry, vol. 279, no. 31, pp. 32633–32642, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Yoshida, M. Ono, T. Shono et al., “Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis,” Molecular and Cellular Biology, vol. 17, no. 7, pp. 4015–4023, 1997. View at Google Scholar · View at Scopus
  67. J. Berg, H. Fellier, T. Christoph, J. Grarup, and D. Stimmeder, “The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro,” Inflammation Research, vol. 48, no. 7, pp. 369–385, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Kohli, J. Ali, M. J. Ansari, and Z. Raheman, “Curcumin: a natural antiinflammatory agent,” Indian Journal of Pharmacology, vol. 37, no. 3, pp. 141–147, 2005. View at Google Scholar · View at Scopus
  69. M. H. Barcellos-Hoff, “Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland,” Cancer Research, vol. 53, no. 17, pp. 3880–3886, 1993. View at Google Scholar · View at Scopus
  70. C. C. Chao, S. Hu, W. S. Sheng, M. Tsang, and P. K. Peterson, “Tumor necrosis factor-α mediates the release of bioactive transforming growth factor-β in murine microglial cell cultures,” Clinical Immunology and Immunopathology, vol. 77, pp. 358–365, 1995. View at Google Scholar
  71. D. E. Sullivan, M. Ferris, D. Pociask, and A. R. Brody, “Tumor necrosis factor-α induces transforming growth factor-β1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway,” American Journal of Respiratory Cell and Molecular Biology, vol. 32, pp. 342–349, 2005. View at Google Scholar
  72. S. Salvioli, E. Sikora, E. L. Cooper, and C. Franceschi, “Curcumin in cell death processes: a challenge for CAM of age-related pathologies,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 2, pp. 181–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. M.-L. Zhang, M. Wu, J.-J. Zhang, D. Irwin, Y.-C. Gu, and Q.-W. Shi, “Chemical constituents of plants from the genus Eupatorium,” Chemistry and Biodiversity, vol. 5, no. 1, pp. 40–55, 2008. View at Publisher · View at Google Scholar · View at Scopus